Is specific immunotherapy safe and effective in children?

European Review for Medical and Pharmacological Sciences

Volumn 4, Issue 5-6, 2000, Pages 139-143

  Cantani, A ^a   Micera, M ^a  

^a Department of Pediatrics   (Italy)

Author keywords

Adverse reactions; Allergic rhinitis; Pediatric asthma; Pediatric SIT; Persistence of respiratory symptoms; Very early onset

Indexed keywords

ADRENALIN; ALLERGEN; ANTIHISTAMINIC AGENT; HOUSE DUST ALLERGEN; POLLEN EXTRACT; STEROID;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION; ALLERGIC DISEASE; ANAPHYLAXIS; ARTICLE; ASTHMA; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EXTRACT; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; INFANT; LARYNX EDEMA; MAJOR CLINICAL STUDY; RESPIRATORY TRACT DISEASE; RISK FACTOR; SHOCK; SYMPTOM; URTICARIA; WHEEZING;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNOTHERAPY;

EID: 0034426052     PISSN: 0392291X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Immunotherapy: Position paper of the Working Group on Immunotherapy of the European Academy of Allergy and Clinical Immunology
2. Immunotherapy: Position paper of the European Academy of Allergy and Clinical Immunology
3. International Consensus Report on Diagnosis, And Management Of Asthma: International Asthma Management Project
4. Global Strategy For Asthma Management And Prevention: WHO/NHLBI Workshop Report
5. International Consensus: Report On The Diagnosis And Management of Rhinitis
6. Injection immunotherapy
7. Practice parameters for allergen immunotherapy
8. WHO position paper: Allergen immunotherapy: Therapeutic vaccines for allergic disease
9. WHO Position Paper Allergen immunotherapy: Therapeutic vaccines for allergic disease
10. Immunotherapy for childhood asthma: Is there a rationale for its use?
11. The appropriate use of skin testing and immunotherapy in young children
12. Systemic reactions occurring during immunotherapy with standardized extracts
13. Specific immunotherapy (SIT) in children
14. Local and systemic reaction during immunotherapy with absorbed extracts of house dust mite in children
15. Systemic reactions to immunotherapy: Comparison between two large allergy practices
16. Immunotherapy: A one-year prospective study to evaluate risk factors of systemic reactions
17. The risk of inducing constitutional reactions in allergic patients
18. Systemic reactions to immunotherapy
19. A prospective national study of the safety of immunotherapy
20. Desensitizing vaccines
21. Late and immediate systemic-allergic reactions to inhalant allergen immunotherapy
22. Systemic reactions to specific immunotherapy in children with respiratory allergy: A prospective study
23. Immediate adverse reactions to immunotherapy in allergy
24. So called fatal anaphylaxis in man
25. Fatalities from immunotherapy (IT) and skin testing (ST)
26. Report On Deaths with Allergenic Extracts
27. Immunotherapy in hay fever with two major allergens 19, 25 and partially purified extract of timothygrass pollen: A controlled doubleblind study
28. Comparison of rush immunotherapy with standardized grasspollen extract and classical immunotherapy with pyridine extracted alum adjuvanted extract
29. Seasonal asthma in northern California: Allergic causes and efficacy of immunotherapy
30. Effective hyposensitization in allergic rhinitis using a potent partially purified extract of house dusts mite
31. Controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with asthma
32. A double-blind multicenter immunotherapy trial in children, using a purified a standardized Cladosporum herbarum preparation
33. Nonfatal systemic allergic reactions induced by skin testing and immunotherapy
34. Survey of fatalities from skin testing and immunotherapy 1985-1989
35. A threeyear controlled study in children with pollinosis treated with immunotherapy
36. Alternaria allergy: A threeyear controlled study in children treated with immunotherapy
37. A three year prospective study of allergen immunotherapy to inhalant allergens: Evidence of safety and efficacy in 300 children with allergic asthma
38. Significant decrease of IgE antibodies after a threeyear controlled study of specific immunotherapy to pollen allergens in children with allergic asthma
39. The growing genetic links and the early onset of atopic diseases in children stress the unique role of the atopic march: A metaanalysis
40. Features of immunotherapy in pediatrics
41. Airway mucosal inflammation even in patients with newly diagnosed asthma
42. Bronchoalveolar lavage findings suggest two different forms of childhood asthma
43. Eosinophilic inflammation in the bronchial mucosa of children with bronchial asthma
44. WHO Position Paper Allergen Immunotherapy: Therapeutic Vaccines For Allergic Diseases
45. International Conference on Allergic Rhinitis in Childhood
46. Risk factors for the persistence of respiratory symptoms in childhood asthma